Ben gibbons is obviously gasher7 from lse.
You can tell by the desperation in his ramps.
Good to see ivenoidea on lse raising the question of Bernie and his track record on keeping to his broken promises…̷0;🤔🤔 |
The block sells continue You're not gonna get a rise here |
Ben the gibbon created the alias 10p-here-we-come
You really couldn’t make it up |
Another great prediction by Ben the gibbon..
The share price fell 20% since then
_________
Ben Gibbens - 05 Jun 2024 - 11:03:10 - 18863 of 20250
Oh well, but when this is 1p+ soon, you'll regret not adding some more in the 0.5's.
Especially when it's 2p. |
What's the great news Ben? |
Great news, KOD could go ballistic. |
RNS NOT LSE.
SORRY again. |
RNS NOT LSE.
SORRY again. |
Lse is often called for but why when CEO & board have no integrity and there admission only cause share price falls.
A Lse from Kodal time after time supports this.Check with official graphs if you have any doubts.
My contact with Americans is similar to here most deep down after the Dollar hate bullies and cowardice,and yet they support Trump who faced with Putin has capitulated.
Given Korea,Afghanistan,Vietnam and their gun outrages at home and lack of ability to
Contain them maybe he shouldn’t be so bombastically errant.
Brits will stand as brits and to blazes with that colony.
A man’s a man for all that. |
 Reddit Rumour @ OBD
A leaked email on Reddit showing communication between OBDs CEO Ross, & the Romanian Health minister. The emails reveal 3 more contracts have been signed in Romania. It also confirms 2 new contracts in Spain have also been lined up.... The 3 Romanian contracts will be announced early next week.
The news of how big the RNS regarding OBDs cancer test success, seems to have been overlooked by the markets. In the RNS the CEO states;
▪︎"Discussions are underway with potential partners to bring this potentially evolutionary test to clinical practice."
He gives that massive "nod" to the market in the 5th RNS!!
RNS from 05/02 [3 main highlights]
▪︎ Results of multi-institutional clinical study published in peerx reviewed journal 'Cancers' confirms efficacy of Oxford BioDynamics' EpiSwitch® blood-based Colorectal No-Stool Test (NST)
▪︎ High accuracy of detection reported at 81% for early cancer stages and 82% for non-cancerous polyps
▪︎ Discussions are underway with potential partners to bring this potentially evolutionary test to clinical practice
12/02 RNS;
"Oxford BioDynamics partners with Regina Maria to offer EpiSwitch clinical tests in Romania
Regina Maria is Romania's largest private healthcare provider, serving 5 million patients
OBD's EpiSwitch PSE and CiRT tests will be available to physicians and patients in Romania as part of Regina Maria's oncology portfolio"
GLA |
Great idea
Pay 100% of the money and own just 66% of the company
BWAHAHAHA |
Happy Friday.
Brilliant to see Kod on the back foot again.
🤔🤔🤔 |
3,000,000 SELL
2,000,000 SELL
3,000,000 SELL
1,000,000 SELL
you just gotta larf innit |
If they launch a fund raise for SC's shares it would be HILAAAAAAARIOUS |
Looks like all yesterday’s hype has gone flat yet again.
Now why am I not surprised 🤔🤔 |
Why are you surprised ? |
Wtf back down again. |
lol this amazing news and the share price goes down |
It's never gonna hit 1p |
Register to chat with like-minded investors on our interactive forums.
Hot Features
Premium
